Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel
Scientists create synthetic form of SBV
Schmallenberg study raises vaccine hopes

Scottish scientists have made a synthetic version of the Schmallenberg virus (SBV) in the laboratory, raising hopes for the development of a vaccine for the disease.

The synthetic version was formed so that scientists were able to study its genetics and how it infects farm animals. They manipulated the virus's genetic sequence so it was more and less severe during the study.

Experiments showed that, if the virus is passed to calves or lambs during pregnancy, it replicates itself in the brain cells and spinal cords of the unborn animals.

Massimo Palmarini and Alan Kohl led the study at the MRC-University of Glasgow Centre for Virus Research.

Professor Palmarini said: "This is the first time we have been able to manipulate the genome of SBV in this way. We now know much more about how the virus causes the disease than we did a couple of months ago."

SBV was first discovered in Germany in November 2011 and has since spread to the UK, via midges that were blown over from the continent. The virus is now carried by native midges, and has affected about 1,000 farms across England and Wales.

An SBV vaccine is currently undergoing tests for European approval.

Become a member or log in to add this story to your CPD history

Defra shares new Sanitary and Phytosanitary guidance

News Story 1
 Defra has published guidance for the vet sector ahead of a proposed UK-EU Sanitary and Phytosanitary agreement.

The agreement, which will change the movement and trade of animals and related products, could see reductions in checks, paperwork and certification. As well as describing regulatory developments, the advice highlights the importance of animal ID, registration and traceability in disease control and other compliance arrangements.

The guidance can be found here. More detail is expected as negotiations progress. 

Click here for more...
News Shorts
BSAVA publishes fifth Manual of Canine and Feline Neurology

The BSAVA has published the fifth edition of its BSAVA Manual of Canine and Feline Neurology.

The new edition has been reviewed and updated, including new developments in diagnostics, therapeutic approaches and clinical decision-making. It is structured to support clinicians through diagnosis, treatment and long-term management.

The guide features five new chapters covering acute myelopathies, chronic myelopathies, emergency protocols, neurotoxicology and neuro-oncology.

It also includes over 100 videos, including demonstrations of neurological examinations, clinical presentations and diagnostic procedures.

Nicola Lloyd, publishing manager, said: "Whether you're a general practitioner seeking practical guidance, or a specialist aiming to refine your expertise, this edition remains an indispensable reference for anyone involved in the care of neurologically compromised dogs and cats."